Dimensional Fund Advisors LP Has $490,000 Position in MoonLake Immunotherapeutics $MLTX
Market Beat·- Dimensional Fund Advisors LP reduced its holdings in MoonLake Immunotherapeutics by 85.7% in the first quarter to 26,307 shares valued at $490,000. - Institutional investors and hedge funds collectively own 93.85% of the company's stock, alongside notable insider selling activity totaling 344,800 shares over a 90-day period. - MoonLake Immunotherapeutics recently reported a quarterly EPS of ($0.84), outperforming consensus estimates, while maintaining a market capitalization of $1.40 billion.